Company Overview and News
Wells Fargo & Company (WFC - Free Report) is aiming to enter the federal student loan refinancing market with a view to bolster its performance, which has of late been impacted by its involvement in a number of legal hassles. The news was reported by Bloomberg.
WFC WFCNP CMA NTRSP CMPWW NTRS
SunTrust Banks, Inc.’s (STI - Free Report) board of directors has approved a 25% hike in the quarterly common stock dividend. The revised quarterly dividend is now 50 cents per share, up from the prior payout of 40 cents. This dividend is payable on Sep 17, to shareholders on record as of Aug 31, 2018. The hike comes as part of the company’s 2018 capital plan which was approved by the Federal Reserve in June.
HD NTRSP PNCFO KEY STI NTRS PNC STI-A PNUCL OXY
The first official third-quarter report on US GDP is more than two months away, but the preliminary nowcasts point to a softer-but-still-solid gain, based on several estimates compiled by The Capital Spectator. The question is whether escalating trade war tension and Turkey's financial crisis that's roiling emerging markets will take a bite out of the rosy projections for the US?
83SF BCS 83SK NTRS NTRSP NYTAB 47MC
Wells Fargo & Company (WFC - Free Report) is aiming to enter the student loan refinancing market with a view to bolster its performance, which has of late been impacted by its involvement in a number of legal hassles. The news was reported by Bloomberg.
WFCNP NTRSP CMPWW NTRS WFC FOX CMA LMHA LMHB FOXA LM
Per an article by Bizjournals, M&T Bank Corporation’s (MTB - Free Report) wealth advisory division — Wilmington Trust Corporation — is nearing the settlement of a lawsuit that has been dragged for almost eight years. The proposed settlement amount of $210 million was approved last month and the bank now looks forward to a final court hearing sometime in the last quarter of 2018.
STI NTRS CMA NTRSP STI-A CMPWW
2018-08-10 fintel.io - 10
Geron Corp. (NASDAQ:GERN) has 146 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 73,720,341 shares. Largest shareholders include FMR LLC / Fidelity, BlackRock Inc., Vanguard Group Inc, BlackRock Fund Advisors, State Street Corp, BlackRock Institutional Trust Company, N.A., Northern Trust Corp, Geode Capital Management, Llc, State of New Jersey Common Pension Fund D, and Bank of New York Mellon Corp.
STT GERN NYMX NTRSP CGC TWMJF BLK NTRS WEED
U.S. Bancorp (USB - Free Report) remains well poised to benefit from improving economic backdrop along with its consistent efforts to drive efficiency and revenues. The company exhibits a well-diversified product mix, capital strength and sound decision-making capabilities.
USB NTRS CMA NTRSP UCTI AVD CMPWW UCTT
BBCN Bancorp Inc. (NASDAQ:BBCN) has 203 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 125,393,593 shares. Largest shareholders include BlackRock Inc., Vanguard Group Inc, BlackRock Fund Advisors, Dimensional Fund Advisors Lp, Fuller & Thaler Asset Management, Inc., Price T Rowe Associates Inc /md/, State Street Corp, Lsv Asset Management, BlackRock Institutional Trust Company, N.
STT HOPE NTRSP BBCN CGC TWMJF BLK NTRS WEED
In the Q2 earnings season, the Finance sector turned out to be one of the best performers. Particularly, benefits from a stabilizing economy and improving interest-rate scenario have well positioned the banking industry. Moreover, lower commercial tax rate are likely to boost banks’ profitability further. In addition, relieving banks from some of the stringent requirements of the Dodd-Frank Act has made the companies optimistic of future earnings growth and raised investors’ sentiments as well.
STI NTRS CMA AMT NTRSP STI-A GTLS
Wells Fargo & Company (WFC - Free Report) is facing yet another probe related to denying or not offering modifications in mortgage loans that about 625 customers were eligible to at the time. Of the impacted customers, homes of about 400 people were foreclosed by the company.
WFC WFCNP CMA NTRSP FUN BGSF CMPWW NTRS
10h - Asif
Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...
11h - Asif
Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...
11h - Asif
General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...
as of ET